BGF European Equity Income A2
Pricing frequency
Daily
Dealing cut off time
10:00
Type
SICAV
Yield
–
NAV
€34.25
Income frequency
-
Ongoing charge
1.82%
Latest actual NAV date
13-11-2026
ISIN
LU0562822386
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 31/10/2026 | % of assets |
|---|---|
| Blk Ics Eur As Liq EnvirtlyAwrAgcyAccTo€ | 3.60 |
| Novartis AG Registered Shares | 3.39 |
| AstraZeneca PLC | 3.33 |
| Roche Holding AG Ordinary Shares new | 2.98 |
| ABN AMRO Bank NV | 2.92 |
| Industria De Diseno Textil SA Share From Split | 2.92 |
| SSE PLC | 2.92 |
| ASR Nederland NV | 2.84 |
| RWE AG Class A | 2.81 |
| Legrand SA | 2.64 |
Investment objective
The Fund seeks an above average income from its equity investments without sacrificing long term capital growth. The Fund invests at least 70% of its total assets in equity securities of companies domiciled in, or exercising the predominant part of their economic activity in, Europe.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.